OUTPACE BIO
Live / Registered — Registered (as of 11 Mar 2025)
What this means for you
Registered since 11 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90173877
- Registration number
- 7724332
- Mark type
- Stylized text
- Filed
- 11 Sept 2020
- Published for opposition
- 14 Sept 2021
- Registered
- 11 Mar 2025
- Attorney of record
- Joi A. White
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy
Owner
- Outpace Bio, Inc., Seattle, WA, US
- Outpace Bio, Inc., Seattle, WA, US
- Outpace Bio, Inc., Seattle, WA, US
Prosecution history
- 11 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 13 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Nov 2024 — USE AMENDMENT FILED
- 24 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 03 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2024 — SOU EXTENSION 5 GRANTED
- 02 May 2024 — SOU EXTENSION 5 FILED
- 02 May 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2023 — SOU EXTENSION 4 GRANTED
- 06 Nov 2023 — SOU EXTENSION 4 FILED